More Chimeric Therapeutics Limited news Chimeric Therapeutics LimitedASX: CHM Additional complete responses in CHM CORE-NK Phase 1b trial Oct 2, 2025 at 4:03 AM UTC As issuedPlain English Chimeric Therapeutics Ltd has released a press release. View Attachment
